| Application no. and date | 20703447.1 (espacenet) (Federated) (European Patent Register), 20200203 | | Patent/reg. no. and date | DK/EP 3917538, 20230712 | | Publication date | 20211208 | | Priority no. and date | GB 201901427, 20190201 | | EP pub. no. and date |
EP 3917538 20211208 | | Effective date | | | Applicant/owner | TETRAGON BIOSCIENCES LTD., Modi'in Technology Park
2 HaMa'ayan Street
Modi'in, 7177871, IL | | Applicant ref. no. | P82750DK01 | | Inventor | ROBERTSON, Adam Brian, c/o Hemispherian AS
Lørenveien 73A
0585 Oslo, NO,
PRIKRYLOVA, Terezia, c/o Hemispherian AS
Lørenveien 73A
0585 Oslo, NO | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/7068 (2006.01) , A61K 31/7072 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) | | Title | DEOXYCYTIDINDERIVATER TIL ANVENDELSE I CANCERTERAPIER | | Int. application no. | EP2020052632 | | Int. publication no. | WO2020157335 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
